Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy

Published:2020-09 Issue: Volume:18 Page:109-117
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

An Ning,Yu Zhuang,He Xin-Jia,Zhao Yuan-Yuan,Yu Li,Zhang Yong-Chun,Lu Hai-Jun,Yang Xue

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province, China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference39 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int. J. Cancer,2019

2. Extended lymph-node dissection for gastric cancer;Bonenkamp;N. Engl. J. Med.,1999

3. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial;Cuschieri;Lancet,1996

4. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial;Cuschieri;Br. J. Cancer,1999

5. Gastric adenocarcinoma;Ajani;Nat. Rev. Dis. Primers,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of disease-free survival of N1/2 non-small cell lung cancer after adjuvant chemotherapy by the biomarker RPMB;Heliyon;2023-07

2. High RPMB predicts poor disease-free survival of male N1 papillary thyroid cancer after adjuvant radioiodine therapy;Heliyon;2022-11

3. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer;Frontiers in Genetics;2022-03-04

4. High RPMB Predicts Better Disease-Free Survival of N1/2 Non-Small Cell Lung Cancer after Adjuvant Chemotherapy;SSRN Electronic Journal;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3